WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

News Articles

6.04.26

Wilson Sonsini Practices, Attorneys Recognized in 2026 Chambers USA Guide
The 2026 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields. This year, the firm received four new practice area rankings, including in the nationwide National Security and Capital Markets: Convertible Debt categories, and three improved practice area rankings.
Client Highlights

4.20.26

Wilson Sonsini Advises Novo Holdings on Route 92 Medical’s $50 Million Growth Financing
On April 7, 2026, Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, announced a $50 million growth financing led by Novo Holdings. New investor Sectoral Asset Management and existing investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group joined in the financing round. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.
Client Highlights

1.28.26

Firm Advises Lead Investor G2 Venture Partners on Waabi’s $1 Billion Fundraise
On January 28, 2026, Waabi, the leader in Physical AI, announced it has closed its oversubscribed $750 million Series C financing round co-led by G2 Venture Partners and Khosla Ventures, and secured an additional milestone-based future investment from Uber to support a new partnership to deploy robotaxis powered by the Waabi Driver exclusively on the Uber platform. The funding, the largest fundraise in Canadian history, will fuel the continued advancement of Waabi’s Physical AI Platform, further accelerate the company’s commercial progress in autonomous trucking, and support Waabi’s expansion into robotaxis. Wilson Sonsini Goodrich & Rosati advised G2 Venture Partners on the transaction.

The Wilson Sonsini team that advised G2 Venture Partners included Danielle Naftulin, Madeleine Vella, Rodrigo Valle, and Tori Fong.

For more information, please see Waabi’s announcement.
Client Highlights

1.13.26

Wilson Sonsini Advises Proxima on $80 Million Seed Financing
On January 13, 2026, Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity therapeutics, announced an oversubscribed $80 million Seed financing.
News Articles

10.17.25

2026 Lawdragon 500 Leading Dealmakers in America Recognizes Wilson Sonsini Attorneys
On October 17, 2025, Lawdragon published the sixth edition of its Leading Dealmakers in America guide, honoring the lawyers who shake the world with the deals they make happen. The list was compiled through Lawdragon’s time-honed methodology, independent journalistic research, robust and simple submissions from as wide of a group as possible, and vetting from established dealmakers and clients.
News Articles

6.05.25

2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights

5.01.25

Wilson Sonsini Advises AssetWatch on $75 Million Series C Financing
On April 30, 2025, AssetWatch, Inc., the fast-growing leader of end-to-end predictive maintenance and condition monitoring solutions, announced the close of a $75 million Series C funding round led by Viking Global Investors. The round also included new investor Harmonic Growth Partners and existing investors Wellington Management, G2 Venture Partners, Triangle Peak Partners, Osage University Partners, and others. Wilson Sonsini Goodrich & Rosati advised AssetWatch on the transaction.

The financing will fuel AssetWatch’s continued growth, expand its AI-powered platform capabilities, accelerate go-to-market initiatives to broaden internationally and in new markets, and strengthen its position as the trusted partner for manufacturers seeking to eliminate unplanned downtime and optimize asset performance.

The Wilson Sonsini team that advised AssetWatch on the transaction included Danielle Naftulin, Jacie Valentine, Maya Prasad, and Jasbir Bains.

For more information, please refer to AssetWatch’s news release. 
Press Releases

4.08.25

Leading Corporate Life Sciences Attorney Danielle Naftulin Joins Wilson Sonsini
PALO ALTO, CA (April 8, 2025) — Wilson Sonsini Goodrich & Rosati, the leading provider of legal services to technology, life sciences, and growth enterprises worldwide, announced that Danielle Naftulin, an accomplished attorney with nearly 25 years of experience advising emerging companies and their venture investors on a broad array of issues and transactions, has joined the firm’s Corporate Department as a partner. Based in the Palo Alto office, Naftulin further expands the firm’s highly regarded life sciences practice, enhancing its ability to meet increasing client demand on both local and national levels.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.